Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07518784) titled 'Accurate Point of Care Liver Disease Diagnostics (Phase 2)' on April 1.
Study Type: Observational
Primary Sponsor: University of California, San Diego
Condition:
MASLD
MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
NAFLD
NAFLD (Nonalcoholic Fatty Liver Disease)
Intervention:
Diagnostic Test: LiverScope(R) exam
Diagnostic Test: MR exam
Diagnostic Test: Blood draw
Other: Body measurements
Recruitment Status: Recruiting
Date of First Enrollment: April 8, 2026
Target Sample Size: 26
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07518784
Pub...